187 related articles for article (PubMed ID: 29191483)
1. Advances in bioresponsive closed-loop drug delivery systems.
Yu J; Zhang Y; Yan J; Kahkoska AR; Gu Z
Int J Pharm; 2018 Jun; 544(2):350-357. PubMed ID: 29191483
[TBL] [Abstract][Full Text] [Related]
2. A review of implantable biosensors for closed-loop glucose control and other drug delivery applications.
Scholten K; Meng E
Int J Pharm; 2018 Jun; 544(2):319-334. PubMed ID: 29458204
[TBL] [Abstract][Full Text] [Related]
3. Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery.
Yu J; Zhang Y; Ye Y; DiSanto R; Sun W; Ranson D; Ligler FS; Buse JB; Gu Z
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8260-5. PubMed ID: 26100900
[TBL] [Abstract][Full Text] [Related]
4. Current trend in drug delivery considerations for subcutaneous insulin depots to treat diabetes.
P V J; Nair SV; Kamalasanan K
Colloids Surf B Biointerfaces; 2017 May; 153():123-131. PubMed ID: 28235722
[TBL] [Abstract][Full Text] [Related]
5. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
[TBL] [Abstract][Full Text] [Related]
6. Modeling Day-to-Day Variability of Glucose-Insulin Regulation Over 12-Week Home Use of Closed-Loop Insulin Delivery.
Yue Ruan ; Wilinska ME; Thabit H; Hovorka R
IEEE Trans Biomed Eng; 2017 Jun; 64(6):1412-1419. PubMed ID: 28113240
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological aspects of closed loop insulin delivery for type 1 diabetes.
Uduku C; Oliver N
Curr Opin Pharmacol; 2017 Oct; 36():29-33. PubMed ID: 28802779
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of automating insulin delivery for the treatment of type 1 diabetes.
Steil GM; Rebrin K; Darwin C; Hariri F; Saad MF
Diabetes; 2006 Dec; 55(12):3344-50. PubMed ID: 17130478
[TBL] [Abstract][Full Text] [Related]
9. Smart approaches to glucose-responsive drug delivery.
Webber MJ; Anderson DG
J Drug Target; 2015; 23(7-8):651-5. PubMed ID: 26453161
[TBL] [Abstract][Full Text] [Related]
10. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
[TBL] [Abstract][Full Text] [Related]
11. Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps.
Pickup JC
Diabetes Technol Ther; 2011 Jul; 13(7):695-8. PubMed ID: 21668344
[No Abstract] [Full Text] [Related]
12. Stimuli-Responsive Insulin Delivery Devices.
Fuchs S; Shariati K; Ma M
Pharm Res; 2020 Sep; 37(10):202. PubMed ID: 32968829
[TBL] [Abstract][Full Text] [Related]
13. Closed loop insulin delivery in diabetes.
Battelino T; Omladič JŠ; Phillip M
Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293
[TBL] [Abstract][Full Text] [Related]
14. Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting.
Barnard KD; Wysocki T; Thabit H; Evans ML; Amiel S; Heller S; Young A; Hovorka R;
Diabet Med; 2015 May; 32(5):601-8. PubMed ID: 25615888
[TBL] [Abstract][Full Text] [Related]
15. Physiology of glucose homeostasis and insulin therapy in type 1 and type 2 diabetes.
Ferrannini E
Endocrinol Metab Clin North Am; 2012 Mar; 41(1):25-39. PubMed ID: 22575405
[TBL] [Abstract][Full Text] [Related]
16. Use of Sitagliptin With Closed-Loop Technology to Decrease Postprandial Blood Glucose in Type 1 Diabetes.
Underland LJ; Ilkowitz JT; Katikaneni R; Dowd A; Heptulla RA
J Diabetes Sci Technol; 2017 May; 11(3):602-610. PubMed ID: 28349708
[TBL] [Abstract][Full Text] [Related]
17. Latest advances in glucose-responsive microneedle-based systems for transdermal insulin delivery.
Martínez-Navarrete M; Pérez-López A; Guillot AJ; Cordeiro AS; Melero A; Aparicio-Blanco J
Int J Biol Macromol; 2024 Apr; 263(Pt 2):130301. PubMed ID: 38382776
[TBL] [Abstract][Full Text] [Related]
18. Closed-loop in children with type 1 diabetes: specific challenges.
Elleri D; Allen JM; Dunger DB; Hovorkea R
Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S131-5. PubMed ID: 21864745
[TBL] [Abstract][Full Text] [Related]
19. Automated overnight closed-loop glucose control in young children with type 1 diabetes.
Elleri D; Allen JM; Nodale M; Wilinska ME; Mangat JS; Larsen AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Technol Ther; 2011 Apr; 13(4):419-24. PubMed ID: 21355719
[TBL] [Abstract][Full Text] [Related]
20. Stimuli sensitive polymers and self regulated drug delivery systems: a very partial review.
Siegel RA
J Control Release; 2014 Sep; 190():337-51. PubMed ID: 24984012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
